Home / Stocks / SYNA

SYNAPTICS (SYNA, Chipmakers) Stock Valuation & Fair Value

Significantly overvaluedPending takeover · $123.00 cash

SYNAPTICS (SYNA, Chipmakers) trades at a current P/E of 24.2, about 48% above its historical normal valuation, with a forward growth estimate of 13.2% and a PEG of 1.83. Analysts' one-year estimates have been hit 27% of the time. Priced at its historical normal P/E of 16.4 on the same blended earnings, the 2026-11-06 close of $116.70 corresponds to about $79.10 a share. This is a valuation reference, not a price target.

How to read these numbers: the PEG ratio and current P/E versus normal P/E.

Current P/E
24.2
Normal P/E
16.4
PEG
1.83
Fwd growth
13.2%
Div yield
0.0%
RSI (14)
57.3
Neutral
Technical context
  • Price $116.70 at the Nov 6 close, 0.8% below the 20-day average ($117.62) and 8.1% above the 50-day ($107.98).
  • RSI (14) at 57.3.
  • 52-week range $58.52 to $147.57: the price is 20.9% below the high and 99.4% above the low.

The Street vs SeerForecast

Wall Street's mean price target for SYNA is $129.33 across 9 analysts, 10.8% above the current price. The average analyst rating is Hold. Our SeerForecast read of the same stock, formed without analyst targets: significantly overvalued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating changed 6 times after 2026-07-31 and is back where it started: significantly overvalued as of 2026-11-02.

Current P/E and rating by weekCurrent P/E moved from 23.4 to 24.5 between 2026-07-31 and 2026-10-30, against a normal P/E of 16.4, with 6 rating changes over 14 recorded weeks.2026-07-31: P/E 23.4, Significantly overvalued, recalculated for the week of 2026-07-312026-07-31: P/E 23.0, Significantly overvalued, recorded live 2026-08-032026-08-07: P/E 23.0, Significantly overvalued, recalculated for the week of 2026-08-072026-08-07: P/E 22.8, Trading above its usual valuation, recorded live 2026-08-102026-08-14: P/E 22.8, Trading above its usual valuation, recalculated for the week of 2026-08-142026-08-14: P/E 23.3, Significantly overvalued, recorded live 2026-08-172026-08-21: P/E 23.3, Significantly overvalued, recalculated for the week of 2026-08-212026-08-21: P/E 20.9, Trading above its usual valuation, recorded live 2026-08-242026-08-27: P/E 20.9, Trading above its usual valuation, recalculated for the week of 2026-08-272026-08-28: P/E 20.9, Trading above its usual valuation, recalculated for the week of 2026-08-282026-08-28: P/E 20.9, Trading above its usual valuation, recalculated for the week of 2026-08-302026-08-28: P/E 20.3, Trading above its usual valuation, recorded live 2026-08-312026-09-04: P/E 20.3, Trading above its usual valuation, recalculated for the week of 2026-09-052026-09-04: P/E 21.0, Trading above its usual valuation, recorded live 2026-09-072026-09-11: P/E 21.0, Trading above its usual valuation, recalculated for the week of 2026-09-122026-09-11: P/E 21.4, Trading above its usual valuation, recorded live 2026-09-142026-09-18: P/E 21.4, Trading above its usual valuation, recalculated for the week of 2026-09-192026-09-18: P/E 19.7, Mixed on our tests, recorded live 2026-09-212026-09-25: P/E 19.7, Mixed on our tests, recalculated for the week of 2026-09-262026-09-25: P/E 21.6, Trading above its usual valuation, recorded live 2026-09-282026-10-02: P/E 21.6, Trading above its usual valuation, recalculated for the week of 2026-10-032026-10-02: P/E 25.4, Significantly overvalued, recorded live 2026-10-052026-10-09: P/E 25.4, Significantly overvalued, recalculated for the week of 2026-10-102026-10-09: P/E 25.1, Significantly overvalued, recorded live 2026-10-122026-10-16: P/E 25.1, Significantly overvalued, recalculated for the week of 2026-10-172026-10-16: P/E 24.5, Significantly overvalued, recorded live 2026-10-192026-10-23: P/E 24.4, Significantly overvalued, recorded live 2026-10-262026-10-30: P/E 24.4, Significantly overvalued, recalculated for the week of 2026-10-312026-10-30: P/E 24.5, Significantly overvalued, recorded live 2026-11-0217.520.022.525.0Jul 31Aug 23Sep 15Oct 7Oct 30Normal P/E 16.4
Mixed on our testsTrading above its usual valuationSignificantly overvaluedLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekCurrent P/EPremium to normal P/ERating
2026-07-31P/E 23.4+47%Significantly overvalued (recalculated)
2026-08-10P/E 22.8+39%Trading above its usual valuation
2026-08-17P/E 23.3+42%Significantly overvalued
2026-08-24P/E 20.9+27%Trading above its usual valuation
2026-09-21P/E 19.7+20%Mixed on our tests
2026-09-28P/E 21.6+32%Trading above its usual valuation (across a rating rules change)
2026-10-05P/E 25.4+55%Significantly overvalued
2026-11-02P/E 24.5+49%Significantly overvalued ← now
Show all 29 readings
WeekCurrent P/EPremium to normal P/ERating
2026-07-31P/E 23.4+47%Significantly overvalued (recalculated)
2026-08-03P/E 23.0+45%Significantly overvalued
2026-08-07P/E 23.0+45%Significantly overvalued (recalculated)
2026-08-10P/E 22.8+39%Trading above its usual valuation
2026-08-14P/E 22.8+39%Trading above its usual valuation (recalculated)
2026-08-17P/E 23.3+42%Significantly overvalued
2026-08-21P/E 23.3+42%Significantly overvalued (recalculated)
2026-08-24P/E 20.9+27%Trading above its usual valuation
2026-08-27P/E 20.9+27%Trading above its usual valuation (recalculated)
2026-08-28P/E 20.9+27%Trading above its usual valuation (recalculated)
2026-08-30P/E 20.9+27%Trading above its usual valuation (recalculated)
2026-08-31P/E 20.3+23%Trading above its usual valuation
2026-09-05P/E 20.3+23%Trading above its usual valuation (recalculated)
2026-09-07P/E 21.0+28%Trading above its usual valuation
2026-09-12P/E 21.0+28%Trading above its usual valuation (recalculated)
2026-09-14P/E 21.4+30%Trading above its usual valuation
2026-09-19P/E 21.4+30%Trading above its usual valuation (recalculated)
2026-09-21P/E 19.7+20%Mixed on our tests
2026-09-26P/E 19.7+20%Mixed on our tests (recalculated)
2026-09-28P/E 21.6+32%Trading above its usual valuation (across a rating rules change)
2026-10-03P/E 21.6+32%Trading above its usual valuation (recalculated)
2026-10-05P/E 25.4+55%Significantly overvalued
2026-10-10P/E 25.4+55%Significantly overvalued (recalculated)
2026-10-12P/E 25.1+53%Significantly overvalued
2026-10-17P/E 25.1+53%Significantly overvalued (recalculated)
2026-10-19P/E 24.5+49%Significantly overvalued
2026-10-26P/E 24.4+49%Significantly overvalued
2026-10-31P/E 24.4+49%Significantly overvalued (recalculated)
2026-11-02P/E 24.5+49%Significantly overvalued ← now

Frequently asked questions

Is SYNAPTICS stock overvalued?

At a current P/E of 24.2 versus its historical normal P/E of 16.4, SYNAPTICS trades about 48% above its typical valuation, with a PEG of 1.83 on 13.2% forward growth. tickerseer currently rates it significantly overvalued.

What is SYNAPTICS's fair value and PEG?

SYNAPTICS trades at a current P/E of 24.2 against a historical normal P/E of 16.4, a PEG of 1.83, and a forward growth estimate of 13.2%. Priced at its historical normal P/E of 16.4 on the same blended earnings, the 2026-11-06 close of $116.70 corresponds to about $79.10 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of SYNAPTICS changed?

tickerseer's rating changed 6 times after 2026-07-31 and is back where it started: significantly overvalued as of 2026-11-02.

What is the analyst price target for SYNAPTICS?

The mean Wall Street price target for SYNAPTICS is $129.33 across 9 analysts, 10.8% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Chipmakers. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.